XML 49 R35.htm IDEA: XBRL DOCUMENT v3.4.0.3
RECEIVABLES (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Jul. 31, 2015
Mar. 31, 2016
Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts receivable, net of reserves   $ 13,400 $ 12,458
Note receivable, current   47,173 46,849
Note receivable, long term   45,889 $ 45,573
Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Proceeds from sale of asset $ 245,000    
Discount rate of future payments to be received 2.80%    
At Time Of Closing | Asset Purchase Agreement      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Present value of future payments to be received $ 46,200    
At Time Of Closing | Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Proceeds from sale of asset 150,000    
Due On First And Second Anniversaries Of Closing | Asset Purchase Agreement      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Present value of future payments to be received 44,900    
Due On First And Second Anniversaries Of Closing | Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Proceeds from sale of asset $ 47,500    
Interest expense | Asklepion Pharmaceuticals, LLC | Asset Purchase Agreement      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accretion on notes receivable   $ 600